Literature DB >> 22029998

Pulmonary hypertension in sickle cell disease.

Mark T Gladwin, Roberto F Machado.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22029998     DOI： 10.1056/NEJMc1109130

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension.

Authors:  Olga Rafikova; Elissa R Williams; Matthew L McBride; Marina Zemskova; Anup Srivastava; Vineet Nair; Ankit A Desai; Paul R Langlais; Evgeny Zemskov; Marc Simon; Lawrence J Mandarino; Ruslan Rafikov
Journal:  Am J Respir Cell Mol Biol       Date:  2018-09       Impact factor: 6.914

2.  An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Authors:  Elizabeth S Klings; Roberto F Machado; Robyn J Barst; Claudia R Morris; Kamal K Mubarak; Victor R Gordeuk; Gregory J Kato; Kenneth I Ataga; J Simon Gibbs; Oswaldo Castro; Erika B Rosenzweig; Namita Sood; Lewis Hsu; Kevin C Wilson; Marilyn J Telen; Laura M Decastro; Lakshmanan Krishnamurti; Martin H Steinberg; David B Badesch; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

3.  Mildly raised tricuspid regurgitant velocity 2.5-3.0 m/s in pregnant women with sickle cell disease is not associated with poor obstetric outcome - An observational cross-sectional study.

Authors:  May C Soh; Srividhya Sankaran; Natali Ya Chung; Catherine Nelson-Piercy; Jo Howard; Sue E Robinson; Eugene Oteng-Ntim
Journal:  Obstet Med       Date:  2016-08-03

Review 4.  Chronic Pulmonary Complications of Sickle Cell Disease.

Authors:  Alem Mehari; Elizabeth S Klings
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.